Charles R. Penn

5.0k total citations · 2 hit papers
36 papers, 4.1k citations indexed

About

Charles R. Penn is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Charles R. Penn has authored 36 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 15 papers in Infectious Diseases and 11 papers in Molecular Biology. Recurrent topics in Charles R. Penn's work include Influenza Virus Research Studies (18 papers), HIV/AIDS drug development and treatment (10 papers) and HIV Research and Treatment (8 papers). Charles R. Penn is often cited by papers focused on Influenza Virus Research Studies (18 papers), HIV/AIDS drug development and treatment (10 papers) and HIV Research and Treatment (8 papers). Charles R. Penn collaborates with scholars based in United Kingdom, United States and Slovakia. Charles R. Penn's co-authors include J. M. Cameron, Richard C. Bethell, David Ryan, Mark von Itzstein, Stuart W. Oliver, Mark L. Smythe, Gaik B. Kok, Wen‐Yang Wu, Betty Jin and Michael S. Pegg and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Biological Chemistry.

In The Last Decade

Charles R. Penn

35 papers receiving 3.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rational design of potent sialidase-based inhibitors of influenza virus replication

1993 1.5k citations Mark von Itzstein, Wen‐Yang Wu et al. Nature profile →
Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection

2010 834 citations Tawee Chotpitayasunondh, Timothy M. Uyeki et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charles R. Penn United Kingdom	19	2.5k	1.5k	1.2k	676	504	36	4.1k
Choung U. Kim United States	28	1.6k 0.6×	1.5k 1.0×	889 0.7×	1.1k 1.6×	326 0.6×	59	3.3k
Richard C. Bethell United Kingdom	29	2.9k 1.2×	2.0k 1.3×	1.0k 0.8×	1.2k 1.7×	392 0.8×	83	5.1k
J. M. Cameron United Kingdom	23	1.7k 0.7×	1.5k 1.0×	1.8k 1.4×	635 0.9×	1.3k 2.6×	35	3.9k
Noel A. Roberts United Kingdom	20	2.2k 0.9×	830 0.6×	1.2k 1.0×	275 0.4×	564 1.1×	32	3.4k
Andrea Carfı́ United States	44	2.6k 1.0×	2.6k 1.8×	1.6k 1.3×	286 0.4×	503 1.0×	91	6.7k
Joanne E. Tomassini United States	35	1.1k 0.4×	1.5k 1.0×	1.3k 1.0×	222 0.3×	467 0.9×	103	4.9k
Arianna Loregian Italy	34	1.8k 0.7×	1.2k 0.8×	527 0.4×	375 0.6×	269 0.5×	112	3.3k
Lijun Rong United States	36	1.3k 0.5×	1.5k 1.0×	1.5k 1.3×	246 0.4×	266 0.5×	160	4.2k
Mark N. Prichard United States	39	3.5k 1.4×	1.4k 0.9×	1.1k 0.9×	356 0.5×	837 1.7×	143	5.4k
Daniel C. Pevear United States	30	1.4k 0.5×	813 0.6×	1.1k 0.9×	347 0.5×	181 0.4×	63	3.5k

Countries citing papers authored by Charles R. Penn

Since Specialization

Citations

This map shows the geographic impact of Charles R. Penn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles R. Penn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles R. Penn more than expected).

Fields of papers citing papers by Charles R. Penn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles R. Penn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles R. Penn. The network helps show where Charles R. Penn may publish in the future.

Co-authorship network of co-authors of Charles R. Penn

This figure shows the co-authorship network connecting the top 25 collaborators of Charles R. Penn. A scholar is included among the top collaborators of Charles R. Penn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles R. Penn. Charles R. Penn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Miller, Paula E., Aksharananda Rambachan, Alison E. Meyer, et al.. (2013). Supply of neuraminidase inhibitors related to reduced influenza A (H1N1) mortality during the 2009–2010 H1N1 pandemic: summary of an ecological study. Influenza and Other Respiratory Viruses. 7(s2). 82–86. 5 indexed citations

Miller, Paula E., Aksharananda Rambachan, Alison E. Meyer, et al.. (2012). Supply of Neuraminidase Inhibitors Related to Reduced Influenza A (H1N1) Mortality during the 2009–2010 H1N1 Pandemic: An Ecological Study. PLoS ONE. 7(9). e43491–e43491. 8 indexed citations

Hurt, Aeron C., Tawee Chotpitayasunondh, Nancy J. Cox, et al.. (2011). Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. The Lancet Infectious Diseases. 12(3). 240–248. 175 indexed citations

Griffin, Thomas W., Raymond Gani, Douglas Fleming, et al.. (2004). Modelling the impact of pandemic influenza in the UK. International Congress Series. 1263. 243–246. 1 indexed citations

Gubareva, Larisa V., Richard C. Bethell, Graham Hart, et al.. (1996). Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en. Journal of Virology. 70(3). 1818–1827. 166 indexed citations

Gray, Norman M., et al.. (1995). The intracellular phosphorylation of (−)-2′-deoxy-3′-thiacytidine (3TC) and the incorporation of 3TC 5′-monophosphate into DNA by HIV-1 reverse transcriptase and human DNA polymerase γ. Biochemical Pharmacology. 50(7). 1043–1051. 65 indexed citations

Gubareva, Larisa V., Charles R. Penn, & Robert G. Webster. (1995). Inhibition of Replication of Avian Influenza Viruses by the Neuraminidase Inhibitor 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic Acid. Virology. 212(2). 323–330. 39 indexed citations

McCauley, John W., et al.. (1995). 4-Guanidino-Neu5Ac2en fails to protect chickens from infection with highly pathogenic avian influenza virus. Antiviral Research. 27(1-2). 179–186. 17 indexed citations

Bethell, Richard C., et al.. (1995). The Kinetics of the Acid-Induced Conformational Change of Influenza Virus Hemagglutinin Can Be Followed Using 1,1′-bis(4-Anilino-5-naphthalenesulphonic Acid). Biochemical and Biophysical Research Communications. 206(1). 355–361. 11 indexed citations

10.

Gray, Norman M., N. Cammack, Kevin N. Cobley, et al.. (1994). Discovery and Analysis of a Series of C2-Symmetric HIV-1 Proteinase Inhibitors Derived from Penicillin. Analytical Biochemistry. 216(1). 89–96.

11.

Penn, Charles R., et al.. (1994). Inhibition of Respiratory Syncytial Virus Replication in vitro by a Pyrazole Dicarboxamide Analogue of Ribavirin. Antiviral chemistry & chemotherapy. 5(5). 340–343. 4 indexed citations

12.

Thomas, Gary, M. Forsyth, Charles R. Penn, & John W. McCauley. (1994). Inhibition of the growth of influenza viruses in vitro by 4-guanidino-2,4-dideoxy-N-acetylneuraminic acid. Antiviral Research. 24(4). 351–356. 43 indexed citations

13.

Itzstein, Mark von, Wen‐Yang Wu, Gaik B. Kok, et al.. (1993). Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature. 363(6428). 418–423. 1465 indexed citations breakdown →

14.

Penn, Charles R., et al.. (1992). Stability of Carbovir, a Potent Inhibitor of HIV, to Phosphorolysis by Human Purine Nucleoside Phosphorylase. Antiviral chemistry & chemotherapy. 3(2). 121–124. 6 indexed citations

15.

Cammack, N., et al.. (1992). Cellular metabolism of (−) enantiomeric 2′-deoxy-3′-thiacytidine. Biochemical Pharmacology. 43(10). 2059–2064. 98 indexed citations

16.

Baxter, Anthony D., et al.. (1991). Synthesis and Biological Activity of Carbocyclic Clitocine. Nucleosides and Nucleotides. 10(1-3). 393–396. 3 indexed citations

17.

McCauley, John W. & Charles R. Penn. (1990). The critical cut-off temperature of avian influenza viruses. Virus Research. 17(3). 191–198. 20 indexed citations

18.

Penn, Charles R.. (1989). The role of RNA segment 1 in an in vitro host restriction occurring in an avian influenza virus mutant. Virus Research. 12(4). 349–359. 5 indexed citations

19.

Penn, Charles R. & Brian W. J. Mahy. (1985). Novel polypeptides encoded by influenza virus subgenomic (DI type) virion RNAs. Virus Research. 3(4). 311–321. 5 indexed citations

20.

Penn, Charles R. & Brian W. J. Mahy. (1984). Capped mRNAs may stimulate the influenza virion polymerase by allosteric modulation. Virus Research. 1(1). 1–13. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact